Okadaic acid inhibits secretion from mast cells, suggesting a regulatory role for protein Ser/Thr phosphatases type I (PP1) and/or 2A (PP2A) in the secretory process. In unstimulated RBL-2H3 cells, okadaic acid pretreatment inhibited PP2A activity in both cytosol and membrane fractions, but inhibition of secretion correlated with inhibition of membrane-bound rather than cytosolic PP2A activity. Okadaic acid had very little effect on PP1 activity. Stimulation of RBL-2H3 cells by antigen led to the activity and amount of PP2A in the membrane fraction increasing nearly 2-fold. In contrast, there was little change in the activity or distribution of PP1. Importantly, the translocation of PP2A was transient, coinciding with or marginally preceding the peak rate of secretion, suggesting a link between PP2A translocation, activity, and secretion. Phorbol 12-myristate 13-acetate plus the calcium ionophore A23187 induced a slower, prolonged rate of secretion that coincided with a similarly protracted translocation of PP2A to the membrane fraction. PP2A translocation is not the only event required for secretion as translocation was also induced by phorbol 12-myristate 13-acetate, without resulting in secretion. These results indicate that increased protein dephosphorylation in the membrane fraction mediated by PP2A is required for mast cell secretion. To our knowledge, this is the first demonstration of a signalmediated, rapid, transient translocation and activation of PP2A in membranes in any system.
Binding of an antigen to receptor-associated IgE on mast cells initiates a well characterized sequence of initial intracellular signals. In general terms, the early events that follow receptor aggregation are increased tyrosine kinase activity, rapid hydrolysis of inositol phospholipids and elevation of intracellular calcium, translocation of protein kinase C (PKC) 1 to the plasma membrane, and phosphorylation of a diverse range of proteins (1, 2) . The culmination of these signals, which occurs over a period of seconds to minutes, is the release of inflammatory mediators (3) . Agents that bypass the IgE receptor can also activate mast cells. The calcium ionophore A23187 (which directly increases intracellular Ca 2ϩ ) induces some secretion from these cells, which, in the added presence of the phorbol ester PMA (which activates PKC), reaches a level of secretion equivalent to that produced by antigen (4, 5) . Much of the current information about intracellular signaling in mast cells has come from the rat basophilic leukemia cell line, RBL-2H3, which is homologous to mucosal mast cells (6) . Recent work in RBL-2H3 cells as well as rat peritoneal mast cells and human lung mast cells has implicated serine/threonine protein phosphatases in the regulation of the secretory process (7) (8) (9) (10) (11) .
Although the reversible covalent modification of proteins by phosphorylation in response to external signals is a dynamic process involving the regulation of both protein kinases and protein phosphatases, precise details of how phosphatases regulate function in any cell system remain unknown (12, 13) . The phosphatases are separated into four major groups, protein phosphatase type 1 (PP1), PP2A, PP2B (calcineurin), and PP2C. PP1 and PP2A are the major intracellular phosphatases, which together account for Ͼ90% of all serine/threonine dephosphorylation reactions (14, 15) . Whereas the catalytic subunits of PP1 and PP2A are ubiquitously distributed and highly conserved, the native forms are complexes of multiple subunits (12, 14, 16) . Specificity of phosphatase action is believed to be determined by additional regulatory subunits within the native complex that target the phosphatases to different subcellular locations and modify the substrate specificity of the catalytic subunits (15, 17) .
A regulatory role for PP1 and/or PP2A in intracellular processes has been implied by the use of two specific inhibitors, okadaic acid and calyculin A. In vitro, okadaic acid blocks both PP1 and PP2A activity at 0.1-10 nM concentrations, although it is 10-fold more effective against PP2A in any one example (14, 18, 19) . Okadaic acid has little or no effect on PP2B or PP2C. Calyculin A in vitro is equipotent against PP1 and PP2A at 0.1-1 nM concentrations (20) , but for both these inhibitors, higher concentrations than those required in vitro are required to see effects in intact cells (19) .
Okadaic acid, in a time-and concentration-dependent manner, inhibits granule-bound mediator release from mast cells (8 -11, 21, 22) . Calyculin A has a similar effect but acts much faster than okadaic acid in RBL-2H3 cells, and there are differences in the concentrations required for inhibition of secretion in RBL-2H3 cells (11) and human lung mast cells (8) . However, because of the high concentrations of PP1 and PP2A inside cells, it has been difficult to use these inhibitors to readily distinguish between the actions of these two phosphatases in intact systems. Therefore whereas these inhibitors imply a modulatory role for PP1 and/or PP2A in the secretory process (22) , the specific phosphatase involved or the mechanism of action remains unresolved in mast cells or indeed in any secretory system.
The aim of this study was to investigate the activity and distribution of PP1 and PP2A in mast cells, within the context of possible modulation by the stimulation of secretion. We show that whereas the activity and subcellular location of PP1 remains unchanged in response to both IgE-dependent and -independent secretagogues, PP2A undergoes a number of distinct changes. Specifically, in response to secretagogues, there is a transient translocation and activation of PP2A in the membrane fraction, which correlates directly with the peak rate of secretion. Strikingly, as the rate of secretion diminishes so too does the membrane association of PP2A. Furthermore, okadaic acid inhibits membrane and cytosolic PP2A activity without any effect on PP1. This work establishes PP2A as the prime phosphatase involved in the mast cell secretory process and introduces a new model system with which to investigate protein phosphatase regulatory mechanisms within a functional context.
EXPERIMENTAL PROCEDURES
Cell Culture, Activation, and Analysis of Secretion-Tissue culture supplies were obtained from Life Technologies, Inc. except for the fetal calf serum which was obtained from CSL Limited (Parkville, VIC, Australia). Maintenance of monolayer cultures of RBL-2H3 cells was in RPMI with 10% fetal calf serum and carried out as described previously (4, 5, 23). 1.5 ϫ 10 6 cells/well in 6-well culture dishes were washed and activated at 37°C in a buffer consisting of 119 mM NaCl, 5 mM KCl, 5.6 mM dextrose, and 0.4 mM MgCl 2 with 25 mM PIPES (pH 7.2). The buffer was supplemented with 0.1% BSA and 1 mM CaCl 2 prior to use. For antigen activation, cells were primed overnight with 75 ng/ml DNPspecific IgE (Sigma) and activated with the specific antigen DNP 24 -BSA (24 molecules of DNP conjugated with one molecule of BSA, hereafter referred to as DNP-BSA) at 100 ng/ml, which was optimal for secretion. The antigen was obtained from two sources. One was a kind gift of Dr. Henry Metzger, NIAMS, National Institutes of Health, Bethesda, MD, and the second was from Calbiochem-Novabiochem. Both sources gave the same results in terms of rate and extent of secretion (data not shown). Where required, cells were activated with 50 nM PMA, 1000 nM calcium ionophore A23187, or the combination of 50 nM PMA and 500 nM A23187 (both from Sigma). Control samples were incubated with buffer alone. After the designated time, the reaction was stopped by placing the samples on ice; the supernatant was removed, and an aliquot was taken for assay of the release of ␤-hexosaminidase. The total cellular content of ␤-hexosaminidase was determined following lysis of unstimulated cultures, and the activated release was expressed as a percentage of total. The amount of ␤-hexosaminidase released was assayed using an absorbance assay with p-nitrophenyl-N-acetyl-␤-Dglucosamide (from Sigma) as the substrate (24) . When phosphatase inhibitors were required, okadaic acid (potassium salt; CalbiochemNovabiochem) was dissolved in buffer and calyculin A (Sigma) was dissolved in dimethyl sulfoxide (Me 2 SO). The final buffer concentration of Me 2 SO was no more than 0.2%, which was added to control cells and had no noticeable effects (11) . Cells were preincubated with the phosphatase inhibitors in activation buffer containing 4 mM glutamine at 37°C for the designated times. Washing the cells free of excess inhibitors had no effect on the inhibitory capacity.
Cell Lysis for Phosphatase Assays and Western Blotting-After activation and removal of the supernatant as above, 0.3 ml of an ice-cold lysis buffer (20 mM Tris-HCl, pH 7.5, 5 mM EGTA, 2 mM EDTA, 1 mM dithiothreitol, 10% glycerol, 0.5 mM phenylmethylsulfonyl fluoride, and 20 g/ml leupeptin, pepstatin, and aprotinin) was added, and the cells were scraped immediately into ultracentrifuge tubes. They were then sonicated (Branson Sonifier, 20% duty cycle, power 2) for 4 ϫ 20 s intervals. The cytosolic fraction was then obtained following centrifugation at 170,000 ϫ g for 23 min (5). The pellet was resuspended, sonicated (2 times as above), and centrifuged as above to give the final membrane fraction, which was resuspended in 100 l of lysis buffer. Aliquots of the cytosol and membrane fractions were removed to assay for protein content using the bicinchoninic acid system (Pierce).
Western Blotting-Proteins (15-25 g/well for cytosol and 20 -30 g/well for membrane) were solubilized in Laemmli sample buffer, then separated on 10% SDS-polyacrylamide gels, and transferred to polyvinylidene difluoride membranes at 400 mA for 2 h. The membranes were washed, and nonspecific binding sites were blocked with 5% w/v skim milk in phosphate-buffered saline. The membranes were incubated for 90 min with the primary antibodies (polyclonal antibodies raised against peptides derived from the C termini of the catalytic subunits of PP1 or PP2A (25) ) and 60 min with the secondary antibodies (Jackson Immunoresearch Laboratories, Westgrove, PA). The level of PP1 and PP2A catalytic subunits in each fraction was determined using an Enhanced Chemiluminescent detection kit (NEN Life Sciences Products) following the manufacturer's instructions. The amount of each subunit present was quantified by scanning the bands on the Kodak x-ray film with a Molecular Dynamics (Sunnyvale, CA) laser densitometer.
Phosphatase Assay-The activity of PP1 and PP2A in cytosol and membrane fractions was determined by measuring the release of trichloroacetic acid-soluble 32 P from 32 P-labeled glycogen phosphorylase (26) . Activity was measured at a protein concentration of 0.1 mg/ml, and PP2A activity was defined as the activity inhibited by 2 nM okadaic acid. Assays were carried out in triplicate, and reactions were restricted to Ͻ20% dephosphorylation to ensure linearity.
RESULTS

Phosphatase Activity in Unstimulated Mast Cells and Effects of Phosphatase
Inhibitors-Initial characterization of phosphatase activity in unstimulated RBL-2H3 cells was carried out using 32 P-labeled phosphorylase as substrate. The total cellular activity of PP1 measured using this standard substrate was over 3-fold greater than that of PP2A (0.61 versus 0.19 units; Table I ). Furthermore, whereas 30% of the total PP1 activity was recovered in the membrane fraction, only 10% of the total PP2A activity was recovered from this fraction. This differential between cytosol and membrane fractions correlated well with Western immunoblot analysis using antisera to the catalytic subunits, which showed that 32.6% of the total PP1 and 6.8% of the total PP2A was membrane-associated (Table I) .
In RBL-2H3 cells, our previous work has shown that the phosphatase inhibitors calyculin A and okadaic acid inhibit secretion in a time-and concentration-dependent manner (11) . To investigate the selective effects of these inhibitors on secretion, we measured the inhibition of both membrane and cytosol P-labeled glycogen phosphorylase as an in vitro substrate. Results for each fraction are given as either units/mg protein or units of total phosphatase activity and are the mean and S.E. of at least eight separate experiments involving triplicate samples. Aliquots of each fraction were separated by SDS-polyacrylamide gel electrophoresis on 10% gels and transferred to polyvinylidene difluoride membranes as detailed under "Experimental Procedures." The presence of PP1 and PP2A were detected on separate membranes using polyclonal antibodies directed against their 36-kDa catalytic subunits. The amount of PP1 or PP2A in each fraction was quantitated as described under "Experimental Procedures," and results are given as a percentage of total phosphatase enzyme and are the mean and S. phosphatase activities and compared this with the degree of inhibition of secretion. After 15 min with 5 nM calyculin A, the cytosol and membrane activity of both PP1 and PP2A were equally inhibited (Fig. 1) . The results are expressed relative to the activity in unstimulated cells that had not been incubated with calyculin A. Calyculin A inhibited PP2A activity slightly more than PP1, and this degree of inhibition was parallel to the inhibition of secretion of 70%. When similar experiments were carried out with okadaic acid, a more dramatic differentiation between the inhibition of PP1 and PP2A was demonstrated (Fig. 2 ). The addition of 1 M okadaic acid to RBL-2H3 cells led to a time-dependent inhibition of the basal activity of PP2A in both the cytosol and membrane fractions with a much more rapid inhibition of PP2A in the cytosol fraction ( Fig. 2A) . Importantly, however, at the same time points, okadaic acid had no effect on the membrane or cytosolic activity of PP1 (Fig. 2B) . It can be seen in Fig. 2A that the degree of inhibition of ␤-hexosaminidase release after 15 min with okadaic acid (stippled bar) is very similar to the degree of inhibition of membrane PP2A activity ( Fig. 2A, solid bar) . At this time point cytosolic PP2A activity is already 90% inhibited, arguing that its activity is not as important in the secretory process. These findings indicate that the inhibition of secretion caused by 1 M okadaic acid pretreatment is mediated only through inhibition of PP2A and not PP1 and that okadaic acid, in these cells, is a better differential inhibitor of PP2A intracellularly as well as in vitro. Phosphatase Activity and Distribution in Antigen-stimulated Mast Cells-To further investigate the role of PP2A in secretion, RBL-2H3 cells were stimulated for specific times by the addition of the antigen, DNP-BSA, and analyzed for the release of ␤-hexosaminidase and the activity and distribution of PP1 and PP2A in cytosol and membrane fractions. Within 2.5 min of stimulation there was an approximately 2-fold increase in both the activity (Fig. 3A) and concentration ( Fig. 3B ) of PP2A in the membrane fraction. Strikingly, the increase in both the membrane activity and level of PP2A was transient, having decreased by 5 min. By 10 min, the activity and levels of PP2A were actually below those seen in unstimulated cells.
Stimulation by antigen had no effect on the activity of PP1, in either the cytosol or membrane fractions (Fig. 3C) , and throughout the time course there was no change seen in the distribution of PP1 in these fractions (data not shown).
Notably, the transient increase in both the level and activity of PP2A in the membrane fraction appeared to correlate with the rate of antigen-induced ␤-hexosaminidase release that peaks around 2.5 min after stimulation (Fig. 4) .
To investigate this correlation more closely, we examined the levels of PP1 and PP2A in the membrane fraction using further time points around the peak rate of secretion. The results revealed that as the level of secretion increased to a peak, so too did the level of PP2A in the membrane fraction. Similarly, as the rate of secretion diminished, so too did the level of membrane-associated PP2A (Fig. 5) . Over the same time course there was no consistent change in the amount of PP1 in the membrane fraction.
Translocation and Activation of PP2A in PMA and A23187-stimulated Mast Cells-It was of interest to determine if PP2A translocation and activation was directly linked to IgE-receptor activation or mediated by other downstream signaling events involved in secretion. Although the PKC activator PMA and calcium ionophore A23187 together induce a similar level of ␤-hexosaminidase release from RBL-2H3 cells as antigen (data not shown), the stimulation mechanism bypasses the aggrega- tion of the IgE receptor and subsequent activation of many of the earliest signaling pathways (4, 5, 30) . As can be seen in Fig.  4 , the time course of antigen-induced ␤-hexosaminidase release differs from that induced by PMA plus A23187. Whereas the peak rate of antigen-induced release is between 2-3 min after stimulation, PMA plus A23187-induced release has a slower onset with a more prolonged peak rate between 4 -6 min after stimulation. Importantly, we determined that this different rate of ␤-hexosaminidase release closely paralleled the rate of translocation of PP2A to the membrane fraction. The addition of PMA plus A23187 to RBL-2H3 cells induces translocation of PP2A to the membrane fraction but with a longer lag time before translocation begins and with a slower rate than observed with antigen (Fig. 6) . The peak of translocation is obtained by 6 min, and the return to the cytosol is also more protracted than that observed with antigen (Fig. 5) . At these time points there was a small but consistent reciprocal decrease seen in the level of PP2A in the cytosol fraction. The change in activity of PP2A in the membrane fraction also follows this extended time course (Fig. 6C) . The translocation of PP2A once again coincides or actually slightly precedes the peak rate of secretion (Fig. 6B) , suggesting that the two events are mechanistically linked. Once again these changes were specific to PP2A, there being no change in the level or activity of PP1 in the cytosol or membrane fractions under the same conditions (data not shown).
Phosphatase Activity and Distribution following Stimulation with PMA Alone-The addition of PMA alone to RBL-2H3 cells does not induce ␤-hexosaminidase release, yet it mimics many of the other changes induced by both antigen and A23187. The cells spread out on the substratum and actomyosin containing plaques, ruffles, and filaments are formed (27, 28) , as well as FIG. 2 . Inhibition by okadaic acid of PP2A activity and antigen stimulated secretion. Adherent monolayers of RBL-2H3 cells that had been incubated overnight with specific IgE were incubated in the presence of 1 M okadaic acid for 15 or 40 min. One group of cells was then lysed, cytosol and membrane fractions were separated, and PP1 and PP2A activity was determined as detailed under "Experimental Procedures." A parallel group of cells was activated by the addition of 100 ng/ml DNP-BSA for 20 min after which the supernatant was removed to measure the release of ␤-hexosaminidase. For the best comparison between PP1 and PP2A in each fraction, the activities are expressed relative to the levels found in unstimulated cells that had not been incubated with okadaic acid (Control). The release data are presented as relative to the levels released by cells activated by DNP-BSA without okadaic acid (OA) pretreatment (Control, 40.4 Ϯ 6.6). A, effect of okadaic acid on PP2A activity and ␤-hexosaminidase release. B, effect of okadaic acid (OA) on PP1 activity and ␤-hexosaminidase release. Results are mean and S.E. of three experiments at 15 min and two at 40 min.
focal adhesions containing vinculin and talin (29) . PMA also leads to the translocation of PKC isozymes to the membrane fraction and the phosphorylation of myosin (4, 5, 23, 30) . We therefore examined the effect of PMA on the distribution and activity of PP2A.
The addition of PMA to RBL-2H3 cells induced the translocation of PP2A to the membrane fraction in a similar time frame to that observed for PMA in the presence of A23187, with a peak at 6 min (Fig. 7A) . This translocation occurred with a reciprocal decrease in the level of PP2A in the cytosol fraction (Fig. 7A) . Surprisingly, however, there was no increase in the level of PP2A activity in the membrane fraction, indeed PP2A activity decreased with the minimum activity being measured at 6 min (Fig. 7B) . This decrease in the basal level of PP2A activity was also transient as the activity increased again as the level of PP2A associated with the membrane fraction diminished. During the same time frame, PMA had little effect on the activity of PP1 in the cytosol or FIG. 3 . Phosphatase PP1 and PP2A activity and distribution in the cytosol and membrane fractions of antigen stimulated RBL-2H3 cells. Adherent monolayers of RBL-2H3 cells that had been incubated overnight with specific IgE were left unstimulated or stimulated by the addition of the antigen, DNP-BSA (100 ng/ml). After the indicated times the supernatant was removed to measure the release of ␤-hexosaminidase, the cells were lysed, cytosol and membrane fractions were separated, and PP1 and PP2A activity in each fraction was assayed as described under "Experimental Procedures." For the best comparison at each time point, the activities and distribution of PP1 and PP2A are expressed relative to the levels found in the unstimulated cells. A, the stimulated activity of PP2A. B, the stimulated levels of PP2A in each fraction following the laser densitometric analysis of Western immunoblots produced as described under "Experimental Procedures." C, the stimulated activity of PP1. The results are mean and S.E. of three separate experiments.
membrane fractions (Fig. 7C) . These intriguing results lead to the proposal that translocation of PP2A to the membrane fraction is necessary but not sufficient to induce secretion and that secretion requires induction of membrane-associated PP2A activity.
DISCUSSION
Previous studies have described the inhibition of mast cell secretion by okadaic acid, implying that PP1 and/or PP2A are essential components of the mast cell intracellular secretory pathway (8 -11, 21, 22) . In the present study we have shown, for the first time in mast cells, that okadaic acid inhibition of secretion correlates with the inhibition of membrane-bound rather than cytosolic PP2A activity. On the other hand, PP1 activity in either fraction was unaffected by okadaic acid under the conditions used, showing it does not contribute to these events of the secretory process. Furthermore, we have shown that stimulation of secretion through the IgE receptor (antigen) or by bypassing the receptor (PMA plus A23187) leads to the FIG. 4 . Rate of antigen-and PMA plus A23187-induced ␤-hexosaminidase release. Adherent monolayers of RBL-2H3 cells that had been incubated overnight with specific IgE were stimulated by the addition of the antigen, DNP-BSA (100 ng/ml), or by the addition of PMA (50 nM) plus A23187 (500 nM). After the indicated times, aliquots of the supernatant were removed to measure the release of ␤-hexosaminidase as described under "Experimental Procedures." The extent of release after 30 min was the same whether induced by antigen (54.7 Ϯ 0.7) or PMA plus A23187 (54.5 Ϯ 5.5) but only the rate over the first 15 min is shown. Results are mean and S.E. of at least five separate experiments.
FIG. 5.
Time course of antigen-stimulated secretion and PP1 and PP2A distribution in the membrane fraction. Adherent monolayers of RBL-2H3 cells that had been incubated overnight with specific IgE were left unstimulated or stimulated by the addition of the antigen, DNP-BSA (100 ng/ml). After the indicated times the supernatant was removed to measure the release of ␤-hexosaminidase, the cells were lysed, and cytosol and membrane fractions were separated. PP1 (PP1c) and PP2A (PP2Ac) in the membrane fraction were detected by Western immunoblotting as detailed under "Experimental Procedures." A, time course of antigen stimulated levels of PP1 and PP2A in the membrane fraction. B, rate of antigen-stimulated ␤-hexosaminidase release at specific time points. The immunoblot is representative of three separate experiments using various time points.
translocation of PP2A to the membrane fraction with a concomitant increase in measured PP2A activity. Moreover, the increased activity and level of PP2A in the membrane fraction is transient, with a time course that closely matches the rate of release of granule-bound mediators. In contrast, activation of mast cells does not alter PP1 activity or distribution. These results lead to the proposal that increased protein dephosphorylation in the membrane fraction mediated by PP2A is required for mast cell secretion.
The low concentration and activity of PP2A measured in the membrane fraction of unstimulated RBL-2H3 cells when compared with the cytosol fraction, is similar to the level of activity and concentration found in membranes of most cells including muscle, hepatocytes (31) and adipocytes (32) . The exception to this rule is neuronal cells, which have a significant proportion of reversibly inactivated membrane-bound PP2A (33) .
In RBL-2H3 cells, we have demonstrated that the time course of the translocation of PP2A to the membrane fraction and the increase in activity correlate closely with the rate of secretion. This correlation is observed in the fast rate of translocation in response to antigen and the slower, more prolonged response to PMA plus A23187. Consistent with this observation, individual batches of RBL-2H3 cells that have earlier peaks of secretion also showed a more rapid translocation of PP2A (data not shown). Other findings confirm this correlation. Pretreatment with okadaic acid for 15 min almost completely FIG. 6 . Time course of PMA؉A23187-stimulated secretion and PP1 and PP2A distribution and activity in the cytosol and membrane fractions. Adherent monolayers of RBL-2H3 cells were left unstimulated or stimulated by the addition of PMA (50 nM) plus A23187 (500 nM). After the indicated times the supernatant was removed to measure the release of ␤-hexosaminidase, the cells were lysed, and cytosol and membrane fractions were separated. PP2A activity and distribution in the cytosol and membrane fractions were determined as detailed under "Experimental Procedures." A, time course of stimulated levels of PP2A (PP2Ac) in the cytosol and membrane fractions that is representative of three separate experiments. B, rate of PMA plus A23187-stimulated ␤-hexosaminidase release at specific time points. C, time course of stimulated activity of PP2A in the cytosol and membrane fractions. Results are mean and S.E. of three separate experiments.
inhibits PP2A activity in the cytosol fraction, whereas the membrane-associated activity is only inhibited by about 50%, which is the same degree by which ␤-hexosaminidase release is inhibited. Our present results therefore indicate that the level of inhibition of secretion by okadaic acid appears to correlate best with the level of PP2A activity in the membrane and not the cytosol fractions. Importantly, although calyculin A inhibits PP1 and PP2A in vitro, it has sometimes been described as a specific inhibitor of PP1 (34) . However, we have shown that calyculin A added to intact cells to inhibit secretion inhibited PP1 and PP2A activity to the same extent in both membrane and cytosol fractions.
Stimulated changes in PP1 and PP2A activity have been described in other cell types but with quite different outcomes to that which we have observed for PP2A in RBL-2H3 cells. Insulin stimulation of rat skeletal muscle cells leads to increased PP1 activity that is accompanied by a corresponding inhibition of PP2A activity (35, 36) . Furthermore, IL-2 stimulation of human CD4 ϩ T cell lines results in a decrease in the activity of both PP1 and PP2A (37) , and adenosine A2 receptor stimulation of polymorphonuclear leukocytes results in an increased PP1 activity in a crude membrane fraction but without any increased translocation of PP1 to that fraction (34) .
Our present observations argue strongly in favor of a mechanistic link between translocation and activation of membraneassociated PP2A and secretion. Our experiments with PMA alone support this activation hypothesis. In the absence of calcium, PMA alone induces the translocation of PP2A to the membrane fraction but does not induce secretion. Under these circumstances, the activity of PP2A in the membrane fraction was reduced. With the addition of A23187, membrane PP2A activity is increased and secretion ensues. It is likely that some of the PP2A resident in the membrane fraction before stimulation also contributes to the secretory response, because, following the peak rate of secretion induced by either antigen or PMA plus A23187, the amount and activity of membrane PP2A actually drops below the basal level (Fig. 4, B and C, and Fig.  7C ). This suggests that an active mechanism for removal of PP2A from the membrane after secretion is stimulated.
Our present findings lead to a number of important questions. First, how is PP2A translocated to the membrane fraction. Second, how might the influx of calcium activate PP2A, and third, what is the role of PP2A in the membrane fraction. With regard to the first question, it is known that the addition of antigen or PMA to RBL-2H3 cells also leads to the translocation of PKC to the membrane fraction (4, 5, 30) . It is therefore possible that the translocation of the two enzymes may be linked. However, it should be noted that PMA-induced translocation of PKC is not transient, whereas PP2A is released from the membrane fraction back into the cytosol within a few minutes. A growing body of evidence indicates that regulation of PP2A occurs through association with other proteins in multiprotein complexes that may include specific kinases (38 -40) . For example A-kinase anchoring protein 79 anchors several signaling enzymes together, including protein kinase A, PKC, and PP2B, and maintains these enzymes in an inactive conformation (41) . Alternatively, PP2A has been shown to be present in complexes containing specific kinases (42, 43) , and in one study, PKC and PP2A were co-localized to the membrane during PKC-mediated cell signaling in COS cells, although the mediator of this co-localization has not been identified (44) . It will be important to identify mast cell-specific binding partners for PP2A.
With regard to the mechanism for activation of membraneassociated PP2A, it is clear that for secretion to occur in RBL-2H3 cells, an increase in intracellular calcium is required (2) . The addition of the calcium ionophore A23187 along with PMA restores the activity of PP2A in the membrane fraction to levels proportional to the amount of enzyme present, suggesting that in some way inhibition of PP2A is removed by an influx of extracellular calcium. PP2A does not require divalent cations for activity in vitro, but calcium may indirectly affect the ac- FIG. 7 . Time course of PMA-stimulated PP1 and PP2A distribution and activity in the cytosol and membrane fractions. Adherent monolayers of RBL-2H3 cells were left unstimulated or stimulated by the addition of PMA (50 nM). After the indicated times the supernatant was removed, the cells were lysed, and cytosol and membrane fractions were separated. PP1 and PP2A activity and distribution in the cytosol and membrane fractions were determined as detailed under "Experimental Procedures." A, time course of stimulated levels of PP2A in the cytosol and membrane fractions that is representative of three separate experiments. B, stimulated PP2A activity in the cytosol and membrane fractions. C, stimulated PP1 activity in the cytosol and membrane fractions. Activity results are mean and S.E. of three separate experiments. tivity of PP2A by affecting its interaction with binding or targeting proteins. Precedence for such a mechanism exists in other signaling complexes, where PKC when bound to A-kinase anchoring protein 79 is inhibited, but as A-kinase anchoring protein 79 also binds Ca 2ϩ /calmodulin with high affinity, the addition of Ca 2ϩ /calmodulin antagonizes the interaction of PKC with A-kinase anchoring protein 79, releasing the inhibition (45) .
With regard to the potential role of membrane-associated PP2A in the secretory process, it has been shown in yeast that a protein dephosphorylation event that is sensitive to okadaic acid and microcystin-LR is necessary for one of the final stages of vacuole fusion (46, 47) . The close correlation of the translocation and activation of PP2A in the membrane fraction with the rate of secretion from RBL-2H3 cells suggests that PP2A may be fulfilling such a role in mast cell secretion. Proteins of the synaptosome-associated protein receptor fusion complex have been described in rat peritoneal mast cells (48) , and we have observed such proteins in RBL-2H3 cells.
2 PP2A in the membrane could become associated with a supramolecular fusion complex.
Whereas the molecular mechanisms responsible for PP2A translocation and activation remain unknown, our results clearly establish that PP2A and not PP1 is the major phosphatase involved in the mast cell secretory process and suggest that PP2A activity in the membrane fraction is required for secretion to proceed. Furthermore, these results are, to our knowledge, the first demonstration of a rapid, signal-mediated transient translocation of PP2A to membranes in any cell system. These results therefore not only have implications for understanding the mechanisms of mast cell secretion and PP2A regulation but may also provide important clues into the molecular mechanisms of exocytosis in general. RBL-2H3 cells may therefore represent a useful model for other secretory systems where the rapid time-course of exocytosis makes detailed molecular analysis difficult.
